These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels. Johansen D; Ytrehus K; Baxter GF Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106 [TBL] [Abstract][Full Text] [Related]
30. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels. Tavackoli S; Ashitkov T; Hu ZY; Motamedi M; Uretsky BF; Birnbaum Y Coron Artery Dis; 2004 Feb; 15(1):53-8. PubMed ID: 15201621 [TBL] [Abstract][Full Text] [Related]
31. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. Imagawa J; Baxter GF; Yellon DM J Cardiovasc Pharmacol; 1998 Jan; 31(1):74-9. PubMed ID: 9456280 [TBL] [Abstract][Full Text] [Related]
32. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Takano H; Tang XL; Bolli R Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2350-9. PubMed ID: 11045972 [TBL] [Abstract][Full Text] [Related]
33. Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits. Ohno Y; Minatoguchi S; Uno Y; Kariya T; Arai M; Yamashita K; Fujiwara T; Fujiwara H Int J Cardiol; 1997 Dec; 62(3):181-90. PubMed ID: 9476676 [TBL] [Abstract][Full Text] [Related]
34. K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia. Genda S; Miura T; Miki T; Ichikawa Y; Shimamoto K J Am Coll Cardiol; 2002 Oct; 40(7):1339-46. PubMed ID: 12383584 [TBL] [Abstract][Full Text] [Related]
35. In swine myocardium, the infarct size reduction induced by U-89232 is glibenclamide sensitive: evidence that U-89232 is a cardioselective opener of ATP-sensitive potassium channels. Rohmann S; Fuchs C; Schelling P J Cardiovasc Pharmacol; 1997 Jan; 29(1):69-74. PubMed ID: 9007673 [TBL] [Abstract][Full Text] [Related]
36. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion. Sheldrick A; Gray KM; Drew GM; Louttit JB Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449 [TBL] [Abstract][Full Text] [Related]
37. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. Auchampach JA; Maruyama M; Cavero I; Gross GJ J Pharmacol Exp Ther; 1991 Dec; 259(3):961-7. PubMed ID: 1762089 [TBL] [Abstract][Full Text] [Related]
38. Adenosine inhibition of neutrophil damage during reperfusion does not involve K(ATP)-channel activation. Zhao ZQ; Todd JC; Sato H; Ma XL; Vinten-Johansen J Am J Physiol; 1997 Oct; 273(4):H1677-87. PubMed ID: 9362230 [TBL] [Abstract][Full Text] [Related]
40. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation. Ford WR; Lopaschuk GD; Schulz R; Clanachan AS Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]